We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

NeoPharm Will Not Face SEC Charges

Law360 (December 1, 2006, 12:00 AM EST) -- Biotech drug maker NeoPharm Inc. announced Friday that the U.S. Securities and Exchange Commission has ended its probe of the company and will not recommend any enforcement action.

The SEC’s formal...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.